181 related articles for article (PubMed ID: 19057983)
1. Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.
Mackenzie GD; Dunn JM; Selvasekar CR; Mosse CA; Thorpe SM; Novelli MR; Bown SG; Lovat LB
Lasers Med Sci; 2009 Sep; 24(5):729-34. PubMed ID: 19057983
[TBL] [Abstract][Full Text] [Related]
2. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.
Mackenzie GD; Jamieson NF; Novelli MR; Mosse CA; Clark BR; Thorpe SM; Bown SG; Lovat LB
Lasers Med Sci; 2008 Apr; 23(2):203-10. PubMed ID: 17610005
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.
Dunn JM; Mackenzie GD; Banks MR; Mosse CA; Haidry R; Green S; Thorpe S; Rodriguez-Justo M; Winstanley A; Novelli MR; Bown SG; Lovat LB
Lasers Med Sci; 2013 May; 28(3):707-15. PubMed ID: 22699800
[TBL] [Abstract][Full Text] [Related]
4. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
5. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
6. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.
Hage M; Siersema PD; van Dekken H; Steyerberg EW; Haringsma J; van de Vrie W; Grool TE; van Veen RL; Sterenborg HJ; Kuipers EJ
Gut; 2004 Jun; 53(6):785-90. PubMed ID: 15138203
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Dunn J; Lovat L
Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
9. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Ackroyd R; Kelty CJ; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Endoscopy; 2003 Jun; 35(6):496-501. PubMed ID: 12783347
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
[TBL] [Abstract][Full Text] [Related]
11. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
13. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus.
Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Stoddard CJ; Reed MW
Dis Esophagus; 2000; 13(1):18-22. PubMed ID: 11005326
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Ackroyd R; Brown NJ; Davis MF; Stephenson TJ; Marcus SL; Stoddard CJ; Johnson AG; Reed MW
Gut; 2000 Nov; 47(5):612-7. PubMed ID: 11034574
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
17. The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
Globe J; Smythe A; Kelty CJ; Reed MW; Brown NJ; Ackroyd R
J Photochem Photobiol B; 2006 Oct; 85(1):17-22. PubMed ID: 16723253
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
19. Treatment for Barrett's oesophagus.
Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
[TBL] [Abstract][Full Text] [Related]
20. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
